A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca, MSD report UK Medicines & Healthcare Regulatory Agency approves Lynparza Olaparib in combination with abiraterone and prednisone or prednisolone to treat metastatic castration-resistant prostate cancer

BD receives FDA 510k clearance for BD Vaginal Panel on the BD COR System; the diagnostic test detects the three most common infectious causes of vaginitis using BD's high-throughput molecular diagnostic platform for large laboratories

Pfizer and BioNTech receive US emergency use authorization of Omicron BA.4/BA.5-adapted bivalent COVID-19 booster in children under 5 years

FDA approves Pfizer’s Zavzpret zavegepant nasal spray for migraines with and without aura that may relieve symptoms within 30 minutes; relief from migraine lasted up to 48 hours for many patients in clinical trial

FDA approves single-dose autoinjector of biosimilar egfilgrastim-cbqv Udenyca for patients undergoing myelosuppressive chemotherapy; single-dose allows for at-home or in-office administration the day after chemotherapy

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count